In this study, we showed whether the plasma C/D ratio is useful to predict tumour CCND1 amplification in preliminary 40 ESCC patients, and examined the diagnostic value of the C/D ratio to detect cancers by comparing findings in ESCC patients and healthy volunteer controls. The gene discussed is CCND1; the disease is cancer.